Aug 14, 2025
BD to Present at Wells Fargo 2025 Healthcare Conference
Aug 07, 2025
BD Reports Third Quarter Fiscal 2025 Financial Results
Jul 23, 2025
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas(TM) Wearable Injector Technology for Biologic Drugs
Jul 07, 2025
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
May 27, 2025
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
May 21, 2025
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
May 13, 2025
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
May 12, 2025
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
Apr 30, 2025
BD to Present at Bank of America Securities Health Care Conference
Mar 20, 2025
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE(TM) Scaffold in Breast Implant Revision Surgery
Feb 13, 2025
BD to Present at Investor Healthcare Conferences
Jan 28, 2025
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25
Jan 22, 2025
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
Jan 13, 2025
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
Nov 20, 2024
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
Nov 19, 2024
BD to Present at the 7th Annual Evercore ISI HealthCONx Conference
Oct 14, 2024
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research
Oct 10, 2024
BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
Sep 26, 2024
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
Sep 03, 2024
BD Completes Acquisition of Critical Care from Edwards Lifesciences